Characteristic sequence motifs located at the genomic breakpoints of the translocation t(12;16) and t(12;22) in myxoid liposarcoma

Pathology

Volumn 40, Issue 6, 2008, Pages 547-552

  Xiang, Hua ^a   Wang, Jian ^b   Hisaoka, Masanori ^c   Zhu, Xiongzeng ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Breakpoints; Chromosomal translocation; DNA sequence; Myxoid liposarcoma

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; PURINE; PYRIMIDINE;

ARTICLE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FUSION GENE; GENE AMPLIFICATION; GENOMICS; HUMAN; HUMAN TISSUE; MYXOSARCOMA; ONCOGENE; POLYMERASE CHAIN REACTION; PROTEIN MOTIF; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 50449108097     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802320424     Document Type: Article

References (32)

1. Aman P, Ron D, Mandahl N, et al. Rearrangement of the transcription factor gene CHOP in myxoid liposarcoma with t(12;16)(q13;p11). Genes Chromosomes Cancer 1992; 5: 278-85.
2. Kuroda M, Ishida T, Takanashi M, et al. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. Am J Pathol 1997; 151: 735-44.
3. Zinszner H, Albalat R, Ron D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev 1994; 8: 2513-26.
4. Dal Cin P, Sciot R, Panagopoulos I, et al. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: Clinicopathological features. J Pathol 1997; 182: 437-41.
5. Pérez-Losada J, Pintado B, Gutiérrez-Adán A, et al. The chimeric FUS/TLS- CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 2000; 19: 2413-22.
6. Hisaoka M, Tsuji S, Morimitsu Y, et al. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Diagn Mol Pathol 1998; 7: 96-101.
7. Panagopoulos I, Lassen C, Isaksson M, et al. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/ CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia. Oncogene 1997; 15: 1357-62.
8. Kanoe H, Nakayama T, Hosaka T, et al. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation. Oncogene 1999; 18: 721-9.
9. Panagopoulos I, Mertens F, Isaksson M, et al. A novel FUS/CHOP chimera in myxoid liposarcoma. Biochem Biophys Res Commun 2000; 279: 838-45.
10. Aoki K, Suzuki K, Sugano T, et al. A novel gene, Translin, encodes a recombination hotspot binding protein associated with chromosomal translocations. Nat Genet 1995; 10: 167-74.
11. Chen SJ, Chen Z, d'Auriol L, et al. Ph1+bcr- acute leukemias: implication of Alu sequences in a chromosomal translocation occurring in the new cluster region within the BCR gene. Oncogene 1989; 4: 195-202.
12. So CW, Ma ZG, Price CM, et al. MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes. Cancer Res 1997; 57: 117-22.
13. Spitzner JR, Muller MT. A consensus sequence for cleavage by vertebrate DNA topoisomerase II. Nucleic Acids Res 1988; 16: 5533-56.
14. Kas E, Laemmli UK. In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics. EMBO J 1992; 11: 705-16.
15. Sander M, Hsieh TS. Drosophila topoisomerase II double-strand DNA cleavage: analysis of DNA sequence homology at the cleavage site. Nucleic Acids Res 1985; 13: 1057-72.
16. Krowczynska AM, Rudders RA, Krontiris TG. The human minisatellite consensus at breakpoints of oncogene translocations. Nucleic Acids Res 1990; 18: 1121-7.
17. Bhagirath T, Abe S, Nojima T, et al. Molecular analysis of a t(11;22) translocation junction in a case of Ewing's sarcoma. Genes Chromosomes Cancer 1995; 13: 126-32.
18. Max EE, Seidman JG, Leder P. Sequences of five potential recombination sites encoded close to an immunoglobulin kappa constant region gene. Proc Natl Acad Sci USA 1979; 76: 3450-4.
19. Adachi M, Tsujimoto Y. Potential Z-DNA elements surround the breakpoints of chromosome translocation within the 5′ flanking region of bcl-2 gene. Oncogene 1990; 5: 1653-7.
20. Boehm T, Mengle-Gaw L, Kees UR, et al. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumors. EMBO J 1989; 8: 2621-31.
21. Wiemels JL, Greaves M. Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia. Cancer Res 1999; 59: 4075-82.
22. Akira S, Okazaki K, Sakano H. Two pairs of recombination signals are sufficient to cause immunoglobulin V-(D)-J joining. Science 1987; 238: 1134-8.
23. Antonescu CR, Tschernyavsky SJ, Decuseara R, et al. Prognostic impact of p53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res 2001; 7: 3977-87.
24. Chalk JG, Barr FG, Mitchell CD. Translin recognition site sequences flank chromosome translocation breakpoints in alveolar rhabdomyosarcoma cell lines. Oncogene 1997; 15: 1199-205.
25. Wei Y, Sun MH, Nilsson G, et al. Characteristic sequence motifs located at the genomic breakpoints of the translocation t(X;18) in synovial sarcomas. Oncogene 2003; 22: 2215-22.
26. Obata K, Hiraga H, Nojima T, et al. Molecular characterization of the genomic breakpoint junction in a t(11;22) translocation in Ewing sarcoma. Genes Chromosomes Cancer 1999; 25: 6-15.
27. Hosaka T, Kanoe H, Nakayama T, et al. Translin binds to the sequencs adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t(12;16). Oncogene 2000; 19: 5821-5.
28. Aoki K, Nakahara K, Ikegawa C, et al. Nuclear proteins binding to a novel target sequence within the recombination hotspot regions of Bcl-2 and the immunoglobulin DH gene family. Oncogene 1994; 9: 1109-15.
29. Spitzner JR, Chung IK, Muller MT. Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats. Nucleic Acids Res 1990; 18: 1-11.
30. Yagil G. Paranemic structures of DNA and their role in DNA unwinding. Crit Rev Biochem Mol Biol 1991; 26: 475-559.
31. Panagopoulos I, Mertens F, Isaksson M, et al. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer 2002; 35: 340-52.
32. Yancopoulos GD, Alt FW. Regulation of the assembly and expression of variable-region genes. Annu Rev Immunol 1986; 4: 339-68.